Vor to Participate in Two Upcoming Investor Conferences
Vor Biopharma (Nasdaq: VOR) announced participation in two upcoming investor conferences. The BofA Securities 2022 Healthcare Conference is set for May 13, 2022, featuring virtual 1x1 meetings. They will also present at the H.C. Wainwright Global Investment Conference on May 24, 2022, with a pre-recorded on-demand presentation available starting at 7:00 AM ET. Investors can access the webcast replay on the company's website, www.vorbio.com. Vor Bio focuses on engineering hematopoietic stem cells for targeted therapies in blood cancers.
- None.
- None.
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that members of its senior management team will be participating virtually in two upcoming investor conferences:
BofA Securities 2022 Healthcare Conference
Date: Friday, May 13, 2022
Virtual 1x1 meetings only
H.C. Wainwright Global Investment Conference
Presentation date: Tuesday, May 24, 2022
Pre-recorded on-demand presentation available beginning at 7:00 AM ET
The on-demand webcast of the presentation at the H.C. Wainwright Global Investment Conference be available on the Company's website at www.vorbio.com. An archived replay of the webcast will also be available.
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Investors & Media
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
FAQ
What conference is Vor Biopharma participating in on May 13, 2022?
When will Vor Biopharma present at the H.C. Wainwright Global Investment Conference?
How can I access Vor Biopharma's presentation from the H.C. Wainwright conference?
What is the focus of Vor Biopharma's research?
Where can I find more information about Vor Biopharma?
